Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Still +54M shares short and time is ticking. 80% inside ownership with a small float.
Hi Doc,
I agree with you.
I have contacted Dr. Pestell several times, and he has always helped and been straight forward.
My wife is a physician, by the way, and she has communicated with him, also.
Scott Kelly always responds, if Pourhassan doesn't.
The global oncology market is projected to be $313.7B by 2026.
https://www.prnewswire.com/news-releases/global-oncology-pharmaceuticals-market-2021-to-2026-featuring-abbvie-bayer-and-novartis-among-others-301394329.html
ACS is a bit of a catch all term for sudden reduced blood flow (ischemia) to the heart .
I only know of the of the CDC acknowledging increased myocarditis in young men after recieving the Moderna vaccine. But, there are journal articles from other countries documenting myocarditis in both mRNA vaccines. Also, the FDA is seeking to restrict access to the mRNA trial data (from FOIA requests) for 55 years for some reason.
I am really only familiar with ASC thru the surgical risk calculator that assesses your risk of cardiac ischemia during or after surgery (where high blood pressure, high cholesterol and smoking are contributing risks). The two mosts serious conditions related to ACS are a Myocardial Infarction (Heart Attack) resulting in cell death that damages or destroys the heart. And, Infarction with ischemia and no cell death. Leaving your function permanently altered and at much higher risk of severe heart attacks leading to death.
That's for the Doc.s on the Board. Could explain some of the complications they are seeing.
mRNA Vaccines dramatically increase inflammation of the endothelium thru T-cell infiltration.
https://www.coronavirustoday.com/2021/11/22/mrna-covid-19-vaccination-increases-endothelial-inflammatory-markers-and-acs-risk
So, Rosenbaum/Patterson illegally solicited shareholders with a bogus Proxy Ballot. Even NP can send out a legal Proxy. Time and time again the 13d group prove they are even less competent then current management.
The 13D group is a bunch of screw ups. We not need that crap.
The only therapy that has shown improved outcomes is Vyzeos produced by Jazz Pharma. I don't know if it is approved for children. Dr. Scott Kelly can tell you whether he thinks Leronlimab can help and he is easy to reach at CYDY
The 13d group look like a bigger crap show then NP and friends.
I agree with you. The plan is to dilute CYDY to buy out IncellDx, IMO
Dilute, dilute, dilute. Kreigsman needs his salary and rent. Rose gardens arn't cheap.
A recently published study showed an 80% efficacy in 39,000 mRNA vaccine recipients for asymptomatic covid-19
https://www.medicalnewstoday.com/articles/covid-19-mrna-vaccines-reduce-symptom-free-cases-by-80#Routine-screening
I agree. Once the trial is unblinded usually take the CRO at least two weeks to run the numbers.
Great find. Thanks!
Thanks for calling BS on this before he pinned the nonsense to the top of the board.
Inflammatory heart damage in recovered Covid-19 patients.
https://www.usatoday.com/story/news/health/2020/07/30/covid-19-patients-suffer-heart-injury-months-after-recovery-study/5536249002/
They are based in New Jersey, not NY. They are part of the Daiichi Sankyo Group in Japan. Your info is erroneous
Yes, the increased mortality rate of hydroxychloroquine is statistically significant. Thanks for posting the article
https://www.targetedonc.com/view/leronlimab-shows-further-promise-for-covid-19-treatment-study-shows
Reposting for those that missed it
Or even worse - you might be investigated by shady shysters
Agree, CYDY is a threat to Gilead
I am surprised to see the Professional Short Distort Machine going after a little OTC company this way. Must be ruffling some Big Pharma feathers with Leronlimab's potential
Awesome!! Great article
Great news. Thanks for the update
I think you are correct about that.
Why would there be trade restrictions between the US and a South Korean company?
Thanks for posting the WJS link
Thank you for this information. It puts everything into perspective.
Agree with that
Quest was purchased by eStudySite, Inc. in 2015. Quest is set up however their parent company wants them to be.
It was a live television broadcast.
Yep, Dr Roger Klein discussed Leronlimab with Neil Cavuto
Monoclonals are commonly used in the brain and directly delivered using a shunt.
Janssen is wholly owned by J&J. The partnership termination PR stated there is a twelve month transition period when Imetelstat related activities will be turned over to Geron.
Nice mention of CYDY - Leronlimab by Zack Hartman this AM in his daily SA article.
That is very interesting, indeed! The lay of the land is changing. Thanks for posting.